1179611

Adam Gerstenblith, M.D. — FEI 3022988777

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hagerstown, MD (United States)

Additional Details

Clinical Investigator (CI)